March 01, 2023 — 09:41 am EST

      Written by
                        RTTNews.com for                             
        




RTTNews ->


(RTTNews) - Perrigo Company plc (PRGO) said Wednesday that the U.S. Food and Drug Administration approved its Abbreviated New Drug Application for Acetaminophen and Ibuprofen Tablets, 250 mg/125 mg, the store brand over-the-counter ("OTC") equivalent of Advil Dual Action Tablets 250 mg/125 mg. The company anticipates launching the product by Spring 2023.
Acetaminophen and Ibuprofen Tablets, 250 mg/125 mg provides relief for multiple pain related symptoms by combining two ingredients indicated for OTC pain relief. Retail sales for the national brand equivalent product for the last twelve months ending January 29, 2023, were about $69 million based on IRI multi-outlet market data.
For More Such Health News, visit rttnews.com 
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

© 2023, Nasdaq, Inc. All Rights Reserved.










To add symbols:


These symbols will be available throughout the site during your session.
To add symbols:


These symbols will be available throughout the site during your session.